Photo: Courtesy of Teva
28 July 2016Americas
Teva’s Allergan acquisition approved by FTC
Teva announced yesterday that the Federal Trade Commission (FTC) has accepted its proposed $40.5 billion buyout of Allergan’s generics business after the Isreal-based company agreed to sell nearly 80 products to address competition concerns.
